Mainstream and sidestream cigarette smoke condensates suppress macrophage responsiveness to interferonγ

Human and Experimental Toxicology

Volumn 18, Issue 4, 1999, Pages 233-240

  Edwards, Kimberlee ^a   Braun, Kristen M ^b   Evans, Glenn ^a   Sureka, Amod O ^a   Fan, Samuel ^a  

^a BRADLEY UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Class II major histocompatibiiity complex; Immunotoxicology; Macrophage; Nitric oxide; Phapocytosis; Respiratory burst

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CIGARETTE SMOKE CONDENSATE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; PEROXIDE; TOBACCO SMOKE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BASAL METABOLIC RATE; CHEMICAL COMPOSITION; COMPARATIVE STUDY; CONFERENCE PAPER; DEVELOPMENTAL DISORDER; ENVIRONMENTAL EXPOSURE; FEMALE; IMMUNE RESPONSE; LUNG INJURY; MACROPHAGE; MOUSE; NEWBORN; NONHUMAN; OPSONIZATION; ORGANOGENESIS; PASSIVE SMOKING; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY BURST; SHEEP ERYTHROCYTE;

ANIMALIA; BACTERIA (MICROORGANISMS); NICOTIANA TABACUM; OVIS ARIES;

EID: 0032945664     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/096032799678839978     Document Type: Conference Paper

References (43)

1. International Agency for Research on Cancer. Coumarin. IARC Monograph 1976; 10: 113-119.
2. Fielding JE. Smoking health effects and control. New Eng J Med 1985; 313: 491-498.
3. Marcy TW, Merrill WW. Cigarette smoking and respiratory tract infection. Clin Chest Med 1987; 8: 381-391.
4. Schilling RSF et al. Lung function, respiratory diseases, and smoking in families. Am J Epidemiol 1977; 106: 274-283.
5. US Surgeon General. The health consequences of involuntary smoking. DHHS (CDC) 87-8398. Washington, DC 1986.
6. Ogston SA, Florey CDV, Walker CHM. Association of infant alimentary and respiratory illness with parental smoking and other environmental factors. J Epidemiol Comm Health 1987; 41: 21-25.
7. Baker RR. Mechanisms of smoke formation and delivery. Rec Adv Tobacco Sci 1980; 6: 184-224.
8. Hoffmann D, Wynder EL. A study of tobacco carcinogenesis. XI. Tumor initiators, tumor accelerators, and tumor promoting activities of condensate fractions. Cancer 1971; 27: 848-864.
9. Hoffmann D, Hecht SS. Advances in tobacco carcinogenesis. In: Grover P. (ed.) Handbook of Experimental Pharmacology, Springer-Verlag, 1989.
10. Sköld CM, Eklund A, Halldén G, Hed J. Autofluorescence in human alveolar macrophages from smokers: Relation to cell surface markers and phagocytosis. Experi Lung Res 1989; 15: 823-835.
11. Streck RJ. A method for isolating human lung macrophages and observations of fluorescent phagocytes from the lungs of habitual cigarette smokers. J Immunol Methods 1994; 174: 67-82.
12. Capelli A, Lusuardi M, Carli S, Donner CF. Acid phosphatase (EC 3.1.3.2) activity in alveolar macrophages from patients with active sarcoidosis. Chest 1991; 99: 546-550.
13. Sherman MP et al. Antimicrobial and respiratory burst characteristics of pulmonary alveolar macrophages recovered from smokers of marijuana alone, smokers of tobacco alone, smokers of marijuana and tobacco, and nonsmokers. Am Rev Respiratory Dis 1991; 144: 1351-1356.
14. Hoogsteden HC et al. Expression of the CD11/ CD18 cell surface adhesion glycoprotein family on alveolar macrophages in smokers and nonsmokers. Chest 1991; 100: 1567-1571.
15. Brown GP, Iwamoto GK, Monick MM, Hunninghake GW. Cigarette smoking decrease IL-1 release by human alveolar macrophages. Am J Physiol 1989; 256: C260-C264.
16. Lepay DA et al. Liver macrophages in murine listeriosis: Cell-mediated immunity is correlated with an influx of macrophages capable of generating reactive oxygen intermediates. J Experi Med 1985; 161: 1503-1512.
17. Evans R. The immunological network at the site of tumor rejection. Biochimica Biophysica Acta 1986; 865: 1-11.
18. Adams DO, Hamilton TA. Phagocytic cells: Cytotoxic activities of macrophages. In: Gallin JI, Goldstein IM, Snyderman R. (eds) Inflammation: Basic principles and clinical correlates, pp. 471-492. Raven Press, Ltd: New York, 1986.
19. Unanue E, Askonas B. The immune response of mice to antigen in macrophages. Immunology 1968; 15: 287-296.
20. Abood EA, Jones MM. Macrophages in developing mammalian skeletal muscle: evidence for muscle fibre death as a normal developmental event. Acta Anatomica (Basel) 1991; 140: 201-212.
21. Trowbridge HO. Immunological aspects of chronic inflammation and repair. J Endo 1990; 16: 54-61.
22. Ferrer I et al Naturally occurring cell death in the cerebral cortex of the rat and removal of dead cells by transitory phagocytes. Neuroscience 1990; 39: 451-458.
23. Brandes ME, Finkelstein JN. Stimulated rabbit alveolar macrophages secrete a growth factor for type II pneumocytes. Am J Respi Cell Mol Biol 1989; 1: 101-109.
24. Nishikawa A et al. Roles of macrophages in programmed cell death and remodeling of tail and body muscle of Xenopus laevis during metamorphosis. Histochem Cell Biol 1998; 109: 11-17.
25. Ganz T. Macrophage function. New Horizon 1993; 1: 23-27.
26. Braun KM et al. Immunotoxicology of cigarette smoke condensates: Suppression of macrophage responsiveness to interferong. Toxicol Applied Pharmac 1998; 149: 136-143.
27. Grimmer G, Naujack KW, Dettbarn G. Gas Chromatographic determination of polycyclic aromatic hydrocarbons, aza-arenes, aromatic amines in the particle and vapor phase of mainstream and sidestream smoke of cigarettes. Toxicology Letts 1987; 35: 117-124.
28. Marino PA, Adams DO. Interaction of bacillus Calmette-Guerin-activated macrophages and neoplastic cells in vitro. I. Conditions of binding and its selectivity. Cell Immunol 1980; 54: 11-25.
29. Fan S, Fehr H-G, Adams DO. Activation of Macrophages for ADCC in vitro: Effects of IL-4, TNF, interferons-α/β, interferon-γ, and GM-CSF. Cell Immunol 1991; 135: 78-87.
30. Slater TF, Sawyer B, Strauli U. Studies on succinate-tetrazolium reductase systems. III. Points of coupling of four different tetrazolium salts. Biochimica Biophysica Acta 1963; 77: 383-393.
31. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
32. b haplotype reveal genetic control of isotype expression. J Immunol 1981; 126: 317-321.
33. Pick E, Mizel D. Rapid microassays for measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods 1981; 46: 211-226.
34. Drapier JC, Hibbs JB. Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 1988; 18: 1587-1592.
35. Dowdy S, Wearden S. Statistics for Research. Wiley: New York. 1983.
36. Mohtashamipur E et al. Comparative carcinogenicity of cigarette mainstream and sidestream smoke condensates on the mouse skin. J Cancer Res Clin Oncol 1990; 116: 604-608.
37. Binns R, Lugton WGD, Wilton LV, Dyas BJ. Inhalation toxicity studies on cigarette smoke: 5. Deposition of smoke particles in the respiratory system of rats under various exposure conditions. Toxicology 1978; 9: 87-102.
38. Hiller FC et al. Deposition of sidestream cigarette smoke in the human respiratory tract. Am Rev Respir Dis 1982; 125: 406-408.
39. Lannan S, Donaldson K, Brown D, MacNee W. Effect of cigarette smoke and it's condensates on alveolar epithelial cell injury in vitro. Am J Physiol 1994; 266: 92-100.
40. Ji CM, Plopper CG, Witsche HP, Pinkerton KE. Exposure to sidestream cigarette smoke alters bronchiolar epithelial cell differentiation in the post natal rat lung. Am J Resp Cell Mol Biol 1994; 11: 312-320.
41. Geiselhart LA, Christian T, Minnear F, Freed BM. The cigarette tar component p-benzoquinone blocks T-lymphocyte activation by inhibiting interleukin-2 production, but not CD25, ICAM-1, or LFA-1 expression. Toxicol Appl Pharmacol 1997; 143: 30-36.
42. Geng Y, Savage SM, Razanai-Boroujerdi S, Sopori ML. Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy. J Immunol 1996; 156: 2384-2390.
43. Li Q et al. Inhibition of human T lymphoblast proliferation by hydroquinone. Toxicol Appl Pharmacol 1996; 139: 317-323.